InvestorsHub Logo
Followers 58
Posts 10080
Boards Moderated 1
Alias Born 09/21/2016

Re: TTTav66 post# 166492

Sunday, 09/23/2018 5:20:46 PM

Sunday, September 23, 2018 5:20:46 PM

Post# of 459685
My, My, My...looks like W/S and others (BIIB, Roche, Lilly) and others in FDA-and the press are going to be seeing and hearing a lot about AVXL Precision medicine w/CNS disease potential over the next month or so.

We recognize new show and tells and we recognize that Dr.M. is delegating AVXL key appearances to SAB members with their reputations and expertise on the line. This little company with science leadership like you read about and Precision Medicine expertise are going to make some noise. Not only will the FDA be pleased but CNS disease patients and caregivers should have something to cheer about, for once. If the media is paying attention we will do well.

Maybe our long darkness is coming to an end. For the sake of every one of the tremendously skilled, well schooled and professional AVXL team here and all the CNS patients from the young Retts kids to the most feeble AD patient hang in there. Between now and the end of 2018 good things are going to happen.

We still have a long way t go but this feels like the end of the beginning in many respects. We just cannot know how the competition will handle this.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News